Long
$ACB: Buy the dip for further upside!
An update. See you all at the top!
An analysis, not an investment advice.
Trade SAFE, trade PATIENTLY & say NO to GREED.
An analysis, not an investment advice.
Trade SAFE, trade PATIENTLY & say NO to GREED.
Note
ACB filed for 750 million shares to be added. Very unexpected and questionable by the company. We may see a further pullback.Note
Up we go! ACB has been selected by the German Bundesinstitut für Arzneimittel und Medizinprodukte BfArM as one of three winners in the public tender to cultivate and distribute medical cannabis in Germany.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.